Logo Creative Business Solutions
Biopharmaceutical Corporate and Business Consultancy
 

ALSA - Courses and Calendar

ALSA is an accredited Continuing Professional Education (CPE) Provider by the Singapore Pharmacy Council

 

2011 Courses

Course

Code

Course Title

Dates

2011

Venue

More

information

113

Medical Devices: From Idea to Market

US and European Regulatory Requirements and Clinical Evaluation Strategies

In collaboration with A*STAR Healthcare and Lifestyle Programme and WMDO

8 CPE Points awarded by the Singapore Pharmacy Council

4-5th July 2011

Biopolis Singapore

more about the course

115 Practical Guidelines for Valuation and Deal- Structuring In Approaching a Strategic Alliance

30th June 2011

(4th intake)

Biopolis Singapore

more about the course

116 Intermediate level - What is Business Development in Biopharmaceuticals and what does the role entail ?
Autumn 2011
to be confirmed
 
117 The Deal Dissection-Where are the Value and Handcuff Articles?

Autumn 2011

to be confirmed

more about the course

Spring 2011 - Successfully completed

In and Out-Licensing Successfully In Biotech and Pharma – Evaluation, Diligence & TPP

Dates: 24-25th March 2011

Venue: NUS NEX Campus, Penang Lane, Singapore

Pharmacists awarded 8 CPE points in accordance to the guidelines of Singapore Pharmacy Council

In collaboration with

more about the course

Keynote lecture: Biopharma Industry - Academia Partnerships, Oxaliplatin, a Blockbuster Case Study

Date: 1st April 2011

Venue: Matrix Biopolis, Breakthrough Theatrette (Free Talk and Lunch)

Kim Bill, Vice President, Debiopharm Group, Founder ALSA

 

In collaboration with

 

more information

Autumn 2010 - Successfully completed

Biotechnology for the Non-Biotechnologist

Dates: 3 - 4th November 2010

Venue: Biopolis, Singapore

In collaboration with

Biotechnology and life sciences are of growing concern to many professionals who do not necessarily have any formal training in biology or an adequate personal knowledge base.

The need for literacy in modern biology among non-scientists is recognized in many domains, in particular in the pharmaceutical industry where biologics have started playing an important role a long time ago and where increasingly sophisticated biomolecular constructs, gene, RNA and cell therapies, nanobiotechnologies, organ regeneration and synthetic biology will clearly occupy an important place in a not so distant future.

Biotechnologists are not necessarily biologists. Indeed, biotechnology is becoming more and more trans-disciplinary in nature with the rapid and massive emergence of new hybrid technologies that combine medicine, agriculture, environmental sciences, robotics, informatics, engineering, and modern biology. Yet, without a basic, yet sound understanding of the latter, it is impossible to fully comprehend these hybrid technologies, nor have any critical outlook on their practical consequences.

This 2 day course will make you a competent biotechnologist by helping you gain literacy in molecular biology and serving as a springboard for further self-directed learning at any point in time in the future.

TESTIMONIALS

Provided a good coverage of material necessary for understanding biotechnology. Exceeded my expectations and glad for the painless introduction to a complex science.
Edward Teoh, Finance Director, Lonza Biologics Tuas Pte Ltd

Instructor delivered more depth than I expected. Exceeded my expectations.
Philip Lim, CEO, Exploit Technologies

This course was supplemented with very comprehensive notes that are easy to understand. Trainer was very clear in his delivery and helped clarify complex science concepts into easy to understand logic. Exceeded my expectations.

Cynthia Liang, Assistant Manager, JTC Corporation

For a beginner, the course really intrigues me. It makes me want to learn more about biotech. There should be a next step after this basic introduction. Met my expectations.
Dessy Arfianni, Commercial Manager, DSM Nutritional Products Asia Pacific Pte Ltd

Overall very well presented. Exceeded my expectations.
Chang Ai-Lien, Senior Correspondent , Enterprise Desk, Singapore Press Holdings